Skip to main content

Table 1 Patient, tumor and surgical characteristics

From: Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers

Characteristics

Group A

(n = 69)

Group B

(n = 58)

Group C

(n = 53)

P value

Mean(range)Age (yrs)

70.6(33-88)

63.1(30-88)

61.2(37-89)

NS

Gender

    

   Male

36

35

35

NS

   Female

33

23

18

 

Comorbidities

   

NS

ASA status

   

NS

   1

11

9

13

 

   2

44

43

34

 

   3

13

6

6

 

   4

1

0

0

 

Type of Surgery

    

   APR

53

49

32

0.04

   ULAR

16

9

21

 

Intent of Surgery

   

NS

   Curative

62

54

49

 

   Palliative

7

4

4

 

Approach (Lap/Open)

16/53

12/46

10/43

NS

Median(range)Operating time(mins)

174.5(80-340)

185.3(75-420)

181.8(100-340)

NS

Median(range)Blood loss intraop (mls)

601(50-3000)

842(99-4200)

654(99-2000)

NS

Pathological tumor stage

    

   1

28

8

2

 

   2

19

28

13

 

   3

16

16

34

 

   4

4

1

4

 

Tumor differentiation

   

NS

   Poor

8

8

12

 

   Moderate

52

38

39

 

   Well

5

4

1

 

Neurovascular involvement

14

13

29

NS

  1. ASA, American Society of Anesthesiologist, APR, abdomino-perineal resection, ULAR, ultra-low anterior resection, NS, not significant